Dimitrios Papantoniou

Joenkoeping, F 55185, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Prognostic performance of thymidine kinase 1 activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with CDK4/6 and aromatase inhibitors.

Prognostic performance of thymidine kinase 1 activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with CDK4/6 and aromatase inhibitors.

Journal: Breast cancer research and treatment

Published: October 13, 2025

Swedish national guidelines on urothelial carcinoma: 2024 update on advanced and metastatic disease.

Swedish national guidelines on urothelial carcinoma: 2024 update on advanced and metastatic disease.

Journal: Scandinavian journal of urology

Published: February 18, 2025

Physical examinations and whole-body imaging versus physical examinations alone during follow-up after radical surgery of stage IIB-C and III cutaneous malignant melanoma (TRIM): an interim analysis of a multicentre, randomised, phase 3 trial in Sweden.

Physical examinations and whole-body imaging versus physical examinations alone during follow-up after radical surgery of stage IIB-C and III cutaneous malignant melanoma (TRIM): an interim analysis of a multicentre, randomised, phase 3 trial in Sweden.

Journal: The Lancet. Oncology

Published: February 11, 2025

Phosphohistone H3 and Ki-67 as prognostic markers in metastatic small intestinal neuroendocrine tumours: A comparative, retrospective cohort study.

Phosphohistone H3 and Ki-67 as prognostic markers in metastatic small intestinal neuroendocrine tumours: A comparative, retrospective cohort study.

Journal: Journal of neuroendocrinology

Published: November 28, 2024

Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients.

Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients.

Journal: Journal of neuroendocrinology

Published: November 12, 2023

Treatment Patterns and Efficacy of Chemotherapy After Pembrolizumab in Advanced Urothelial Cancer-a Real-World Study in the pre-Antibody-Drug Conjugate Era.

Treatment Patterns and Efficacy of Chemotherapy After Pembrolizumab in Advanced Urothelial Cancer-a Real-World Study in the pre-Antibody-Drug Conjugate Era.

Journal: Clinical genitourinary cancer

Published: February 03, 2023

Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort.

Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort.

Journal: Endocrine-related cancer

Published: December 14, 2022

Outcomes of Patients with Advanced Urothelial Carcinoma after Anti-programmed Death-(ligand) 1 Therapy by Fibroblast Growth Factor Receptor Gene Alteration Status: An Observational Study.

Outcomes of Patients with Advanced Urothelial Carcinoma after Anti-programmed Death-(ligand) 1 Therapy by Fibroblast Growth Factor Receptor Gene Alteration Status: An Observational Study.

Journal: European urology open science

Published: November 02, 2022

Activity and safety of KEES - an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer.

Activity and safety of KEES - an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer.

Journal: BMC cancer

Published: October 30, 2022

Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study).

Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study).

Journal: Cancers

Published: January 19, 2022

Real-world evaluation of upfront docetaxel in metastatic castration-sensitive prostate cancer.

Real-world evaluation of upfront docetaxel in metastatic castration-sensitive prostate cancer.

Journal: World journal of clinical oncology

Published: March 23, 2021

Systemic treatment in patients with malignant pleural mesothelioma - real life experience.

Systemic treatment in patients with malignant pleural mesothelioma - real life experience.

Journal: BMC cancer

Published: February 09, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026